| Rank | Title | Authors | Published | TL;DR | Keywords | Score |
|---|---|---|---|---|---|---|
| 1 | Quantitative mapping of dynamic 3D transport in growing cells via volumetric spatio-temporal image correlation spectroscopy (vSTICS) | Ahmad Mahmood, Paul W. Wiseman | 2026-03-29 | Novel vSTICS framework quantifies 3D flow, diffusion, and particle density in living cells using spatio-temporal correlation analysis on volumetric fluorescence imaging. | volumetric spatio-temporal image correlation spectroscopy, lattice light-sheet microscopy, spatio-temporal correlation analysis, imaging-FCS, reverse-fountain model | 10 |
| 2 | Self-evolving AI agents for protein discovery and directed evolution | Yang Tan, Lingrong Zhang, Mingchen Li, et al. | 2026-03-28 | VenusFactory2 autonomously discovers and optimizes proteins using self-evolving multi-agent AI framework that synthesizes dynamic workflows from natural language prompts. | multi-agent systems, directed evolution, protein optimization, workflow synthesis, VenusAgentEval | 9 |
| 3 | Cardiovascular-Kidney-Metabolic Health: Insights from Wearables and Blood Biomarkers | Zeinab Esmaeilpour, A. Ali Heydari, Daniel McDuff, et al. | 2026-03-29 | Integrates wearable sensor data with biomarkers to characterize cardiovascular-kidney-metabolic syndrome heterogeneity and identify early predictors of organ-specific health decline. | HOMA-IR, normalized deviance score, feature ablation analysis, multi-system subtyping, wearable-derived phenotypes | 7 |
Daily Summary
Today's q-bio.QM digest highlights significant methodological advances across computational imaging, AI-driven protein engineering, and multi-modal health monitoring. The top-ranked work introduces volumetric spatio-temporal correlation spectroscopy (vSTICS) for 3D intracellular transport mapping, while AI-powered autonomous agents demonstrate breakthrough capabilities in protein discovery and directed evolution. Wearable biosensor integration with clinical biomarkers emerges as a powerful approach for early detection of complex multi-organ syndromes, underscoring the field's shift toward high-dimensional, multi-scale quantitative biology.